Case Studies

Guide the evolution of a pre-approval access policy for gene therapy (DMD)

Context

Work with a top 20 pharmaceutical company to guide the evolution of their public policy for providing pre-approval access to gene therapy

Customized Approach

Detailed landscape analysis, background research to identify the needs of the community
External stakeholder engagement
Patient advocacy consultation on all stages of the process

Outcome

A policy designed and written to reflect the needs of the community

How else can we help?

Discover more about the services and capabilities Bionical Emas has to offer

READ MORE

Clinical Development

READ MORE

Clinical Trial Supply

READ MORE

Early Access Programs